DermTech, Inc. announced that on January 29, 2024, Claudia Ibarra and the Company mutually agreed Ms. Ibarra?s last day of employment as chief operating officer of the Company will be February 2, 2024. The Company intends to enter into a separation agreement with Ms. Ibarra, the terms of which will be disclosed after such terms are available.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4995 USD | -12.54% | -20.04% | -71.46% |
May. 14 | Earnings Flash (DMTK) DERMTECH Posts Q1 Revenue $3.8M | MT |
Apr. 22 | North American Morning Briefing : Stock Futures -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-71.46% | 17.29M | |
-4.67% | 12.32B | |
-5.19% | 8.07B | |
+9.45% | 5.91B | |
+28.50% | 5.52B | |
-8.09% | 4.21B | |
+13.49% | 2.73B | |
-1.34% | 2.43B | |
+32.24% | 2.29B | |
-3.55% | 1.89B |
- Stock Market
- Equities
- DMTK Stock
- News DermTech, Inc.
- Dermtech, Inc. Announces Cessation of Claudia Ibarra as Chief Operating Officer